Open AccessA narrative review of emergency use authorization versus full FDA approval and its effect on COVID-19 vaccination hesitancy
Author(s) -
Thoyaja Koritala,
Akhtar Hussain,
Yelena Pleshkova,
Lavanya Dondapati,
Raghavendra Tirupathi,
Ali Mandegary,
Abbas Al Mutair,
Saad Alhumaid,
Jaffar A. AlTawfiq,
Rahul Kashyap
Publication year - 2021
Publication title -
le infezioni in medicina
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 22
eISSN - 2532-8689
pISSN - 1124-9390
DOI - 10.53854/liim-2903-4
Subject(s) - covid-19 , authorization , vaccination , herd immunity , medicine , narrative review , pandemic , medical emergency , intensive care medicine , computer security , immunology , virology , computer science , disease , pathology , outbreak , infectious disease (medical specialty)
COVID-19 pandemic affected the lives of many with its devastating mortality and morbidity. Acquisition of herd immunity is one way to mitigate the spread of infection. Many factors influence the acceptance of vaccination including the regulatory process of the vaccines. This review article will briefly summarize the Emergency Use Authorization, Full FDA Approval process and highlight how the key factors affecting the vaccination hesitancy, are being influenced by the lack of Full FDA Approval.